Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 6:37 PM UTC
| NCT Number | NCT05774951 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE3 |
| Target Enrollment | 4,300 participants |
| Active Locations | 127 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | June 17, 2026 (Jun 17, 2026) |
As of July 20, 2026: Clinical trial NCT05774951 is currently recruiting participants. This phase3 study for breast cancer is actively seeking new participants at 127 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05774951 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 127 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05774951 was last updated Jun 17, 2026 (June 17, 2026). HelloStudys verifies this status automatically.